TickerFactsScreenerDevelopers

SUPERNUS PHARMACEUTICALS, INC. (SUPN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2009: $31.41M2010: $23.74M2011: $48.54M2012: $40.30M2013: $32.98M2014: $36.40M2015: $33.50M2016: $66.40M2017: $100.30M2018: $192.25M2019: $181.38M2020: $288.64M2021: $203.43M2022: $93.12M2023: $75.05M2024: $69.33M2025: $128.45M$128.45M
2009Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$128.45M+85.3%
2024$69.33M-7.6%
2023$75.05M-19.4%
2022$93.12M-54.2%
2021$203.43M-29.5%
2020$288.64M+59.1%
2019$181.38M-5.7%
2018$192.25M+91.7%
2017$100.30M+51.1%
2016$66.40M+98.2%
2015$33.50M-8.0%
2014$36.40M+10.4%
2013$32.98M-18.2%
2012$40.30M-17.0%
2011$48.54M+104.5%
2010$23.74M-24.4%
2009$31.41M—